Meldungen aus Staines-Upon-Thames, England

26.03.2019 – 15:30
Mallinckrodt Plc.
Mallinckrodt Announces 2019 Investigator Award for Pioneering Efforts in ECP Immunomodulation
EUR50,000 award goes to Newcastle University, in collaboration with Medical University, Graz and Newcastle Hospitals NHS Foundation Trust Staines-Upon-Thames, England (ots/PRNewswire) - Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced the recipient of 2019's Advancing Extracorporeal Photopheresis (ECP) Immunomodulation ...
mehr
20.03.2018 – 09:02
Mallinckrodt Plc.
Mallinckrodt Announces First Investigator Award for Pioneering Efforts in ECP Immunomodulation
Staines-Upon-Thames, England (ots/PRNewswire) - EUR50,000 award goes to Rotherham NHS Foundation Trust Department of Haematology Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced the inaugural recipient of its Advancing Extracorporeal Photopheresis (ECP) Immunomodulation Investigator Award. The winning entry was submitted by ...
mehr